Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · October 16, 2024

Efficacy of Sintilimab Plus Bevacizumab Combined With Radiotherapy in Patients With Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatology (Baltimore, Md.)

 

Additional Info

Hepatology (Baltimore, Md.)
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
Hepatology 2024 Oct 01;80(4)807-815, M Zhu, Z Liu, S Chen, Z Luo, J Tu, L Qiao, J Wu, W Fan, Z Peng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading